APA (7th ed.) Citation

Brandal, S. H. B., Mo, T., Fangberget, A., Nilsen, L. B., Geier, O. M., Bjørndal, H., . . . Seierstad, T. (2026). MRI for Predicting Response and 10-Year Outcome of Neoadjuvant Chemotherapy with or Without Additional Bevacizumab Treatment in HER2-Negative Breast Cancer. Cancers, 18(3), 393. https://doi.org/10.3390/cancers18030393

Chicago Style (17th ed.) Citation

Brandal, Siri Helene Bertelsen, et al. "MRI for Predicting Response and 10-Year Outcome of Neoadjuvant Chemotherapy with or Without Additional Bevacizumab Treatment in HER2-Negative Breast Cancer." Cancers 18, no. 3 (2026): 393. https://doi.org/10.3390/cancers18030393.

MLA (9th ed.) Citation

Brandal, Siri Helene Bertelsen, et al. "MRI for Predicting Response and 10-Year Outcome of Neoadjuvant Chemotherapy with or Without Additional Bevacizumab Treatment in HER2-Negative Breast Cancer." Cancers, vol. 18, no. 3, 2026, p. 393, https://doi.org/10.3390/cancers18030393.